Autopsy report · NCT05084534

Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“No cases of refractory ascites presented to hospital in one year”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Na
Sponsor: Institute of Liver and Biliary Sciences, India
Sponsor type: University, hospital or other
Conditions: Refractory Ascites in Children With Cirrhosis
Interventions: Midodrine; Standard medical treatment
Participants: 0
Sites: 1
Countries: India

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.